Article
Des Plaines, IL-European regulatory officials have cleared the use of Addition Technology Inc.'s micro-thin prescription inserts (Intacs) for the treatment of keratoconus.
Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
CHMP issues positive opinion for the marketing authorization of FYB203, a biosimilar candidate to aflibercept
Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy